Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aqueous Humor Dynamics of NCX 470 (Whistler)
NCT05938699Phase 3Completed
- Sponsor
- Nicox S.A.
- Start
- Dec 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of NCX 470 in ocular hypertension, open-angle glaucoma (OAG), sponsored by Nicox S.A.. Started Dec 2023; status: completed.
02
Drugs
NCX 470
03
Conditions
ocular hypertensionopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT05938699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05938699.